The answer is very clear that if you have MI and preserved EF, there is no benefit of using a beta-blocker. Sripal Bangalore ...

NEW ORLEANS, LA—Sodium-glucose cotransporter 2 (SGLT2) inhibition does not seem to be a solution to the problem of arrhythmia ...

NEW ORLEANS, LA—Complete revascularization in patients presenting with ACS and multivessel coronary artery disease ...

For patients with aortic stenosis, is earlier intervention beneficial? Mamas Mamas, Philippe Généreux, Nicolas Van Mieghem, ...

Mortality/major ischemic events at 90 days were no lower than with a restrictive strategy—but cardiac complications differed.

The device may help boost early detection of HFrEF for people living in low-resource settings where echo is scarce.

An oral agent is needed because some patients don’t like injectables, and some doctors don’t prescribe them, experts say.

With such a large reduction, coupled with general skepticism around PUFAs, experts would like to see the trial replicated.

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.

The drug, given as a weekly subcutaneous injection, reduced both triglycerides and liver fat in the phase II trial.

The noninferiority trial of patients at risk for both bleeding and stroke, in a surprise turn, found standard care to be ...